Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme (Q58856060)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Laura Maiore

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Luigi Messori

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Lara Massai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Federica Scaletti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Elena Michelucci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Maria Agostina Cinellu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

7 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Inorganic Chemistry

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

1293-1302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00775-012-0952-6

17 February 2020

exact match

0 references

cites work

Gold derivatives for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Gold(III) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Protein targets for anticancer gold compounds: mechanistic inferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Interactions of gold coordination complexes with DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Reactions of gold(III) complexes with serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

X-ray absorption spectroscopy studies of the adducts formed between cytotoxic gold compounds and two major serum proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

[Au2(phen(2Me))2(μ-O)2](PF6)2, a Novel Dinuclear Gold(III) Complex Showing Excellent Antiproliferative Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Structural characterization, solution studies, and DFT calculations on a series of binuclear gold(III) oxo complexes: relationships to biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Anticancer metal compounds in NCI's tumor-screening database: putative mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Probing the interaction of cisplatin with cytochrome C by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Structural studies of the effect that dimethyl sulfoxide (DMSO) has on cisplatin and carboplatin binding to histidine in a protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Recent progress in the application of analytical techniques to anticancer metallodrug proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: new insights from X-ray diffraction and mass spectrometry studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

The thioredoxin system in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Thioredoxin reductase as a novel molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Cellular copper distribution: a mechanistic systems biology approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Evidence for operation of the direct zinc ligand exchange mechanism for trafficking, transport, and reactivity of zinc in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Chemistry of Ni2+ in urease: sensing, trafficking, and catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

Insights in the (un)structural organization of Bacillus pasteurii UreG, an intrinsically disordered GTPase enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-012-0952-6

A new structural transition of serum albumin dependent on the state of Cys34. Detection by 1H-NMR spectroscopy

21 January 2018

1 reference

12 December 2020

A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]− to human serum albumin

1 reference

12 December 2020

First Crystal Structure of a Medicinally Relevant Gold Protein Complex: Unexpected Binding of

1 reference

12 December 2020

Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies

1 reference

12 December 2020

Kinetics and Mechanism of the Reaction between Serum Albumin and Auranofin (and Its Isopropyl Analogue) in Vitro

1 reference

12 December 2020

10.1007/S00775-012-0952-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132507%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference